Among 284 articles from Chinese databases and 55 written by Chinese researchers from PubMed, preclinical drug studies accounted for the highest proportion (57.5%), followed by 17.4% on clinical studies, 17.1% on drug resistance and susceptibility, 6.5% on drug safety and adverse effects, and 1.5% on other related subjects such as Glucose-6-phosphate dehydrogenase (G6PD) deficiency. Here, G6PD is linked to G6PD deficiency.